Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes.

导出 LinkOut

翻译打印收藏纠错

作者： Motonori,Sato ^[1] ; Yoshifumi,Tamura ^[1] ; Hideyoshi,Kaga ^[2] ; Nozomu,Yamasaki ^[1] ; Mai,Kiya ^[1] ; Satoshi,Kadowaki ^[1] ; Daisuke,Sugimoto ^[1] ; Takashi,Funayama ^[1] ; Yuki,Someya ^[1] ; Saori,Kakehi ^[2] ; Shuko,Nojiri ^[2] ; Hiroaki,Satoh ^[3] ; Ryuzo,Kawamori ^[1] ; Hirotaka,Watada ^[1]

作者单位： Department of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[1] Sportology Center, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[2] Clinical Research Center, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[3] Center for Therapeutic Innovations in Diabetes, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[4] Center for Identification of Diabetic Therapeutic Targets, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[5]

关键词 SGLT2 inhibitor ectopic fat hyperinsulinemic euglycemic clamp insulin clearance insulin resistance

DOI 10.3390/biomedicines9091154

PMID 34572340

发布时间 2021-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicines

2021年9卷9期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes.

Biomedicines

相似文献

Biomedicines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes.

Biomedicines

相似文献

Biomedicines

相关期刊

检索历史清除